IDS 2013* , ,
Presentations this author is a contributor to:
Antithymocyte globulin therapy for patients with recent-onset type 1 diabetes: metabolic and mechanistic outcomes from the START trial (#6)
9:15 AM
Stephen E Gitelman
MECHANISTIC ANALYSIS OF CLINICAL TRIALS I
Lymphocyte changes during alefacept treatment in newly diagnosed Type 1 diabetes (#15)
2:35 PM
Mark R Rigby
CLINICAL RESEARCH